Search results for "(Q)SAR"

showing 10 items of 48 documents

Quantitative Structure-Antioxidant Activity Models of Isoflavonoids: A Theoretical Study

2015

Seventeen isoflavonoids from isoflavone, isoflavanone and isoflavan classes are selected from Dalbergia parviflora. The ChEMBL database is representative from these molecules, most of which result highly drug-like. Binary rules appear risky for the selection of compounds with high antioxidant capacity in complementary xanthine/xanthine oxidase, ORAC, and DPPH model assays. Isoflavonoid structure-activity analysis shows the most important properties (log P, log D, pKa, QED, PSA, NH + OH ≈ HBD, N + O ≈ HBA). Some descriptors (PSA, HBD) are detected as more important than others (size measure Mw, HBA). Linear and nonlinear models of antioxidant potency are obtained. Weak nonlinear relationship…

Quantitative structure–activity relationshipAntioxidantantioxidantStereochemistryDPPHDalbergiamedicine.medical_treatmentQuantitative Structure-Activity RelationshipFlavonesArticleAntioxidantsCatalysisInorganic Chemistrylcsh:Chemistrychemistry.chemical_compoundIsoflavonoidmedicineStructure–activity relationshipPhysical and Theoretical ChemistryXanthine oxidaseMolecular Biologylcsh:QH301-705.5Spectroscopychemistry.chemical_classificationChemistryQSARstructure-activity relationshippoor absorption or permeationOrganic ChemistryGeneral MedicineIsoflavonesIsoflavonesComputer Science ApplicationsADMETBiochemistrylcsh:Biology (General)lcsh:QD1-999Oxidation-ReductionabsorptionInternational Journal of Molecular Sciences
researchProduct

Combined use of PCA and QSAR/QSPR to predict the drugs mechanism of action. An application to the NCI ACAM Database

2009

During the years the National Cancer Institute (NCI) accumulated an enormous amount of information through the application of a complex protocol of drugs screening involving several tumor cell lines, grouped into panels according to the disease class. The Anti-cancer Agent Mechanism (ACAM) database is a set of 122 compounds with anti-cancer activity and a reasonably well known mechanism of action, for which are available drug screening data that measure their ability to inhibit growth of a panel of 60 human tumor lines, explicitly designed as a training set for neural network and multivariate analysis. The aim of this work is to adapt a methodology (previously developed for the analysis of …

Quantitative structure–activity relationshipMultivariate analysisDatabaseArtificial neural networkMechanism (biology)Computer scienceOrganic Chemistrycomputer.software_genreSettore CHIM/08 - Chimica FarmaceuticaComputer Science ApplicationsSet (abstract data type)Mechanism of actionTest setDrug DiscoveryPrincipal component analysisAnti-cancer Agent Mechanism database PCA QSAR/QSPR Mechanism of actionmedicineData miningmedicine.symptomcomputer
researchProduct

Molecular modelling and QSAR in the discovery of HIV-1 integrase inhibitors

2007

The treatment regimens for the HIV-1 have mainly included reverse transcriptase or protease inhibitors but their long-term clinical utility is limited by severe side effects and viral drug resistance. A new attractive target for chemotherapeutic intervention can be the Integrase enzyme, that mediates the integration of HIV-1 DNA into a host chromosome, for which there is no known counterparts in the host cell. A number of derivatives have been found to inhibit IN in in vitro assays, but no successful drug based on them has emerged so far, although many compounds have been proposed. Moreover most of the inhibitors do not belong to a very precise structural class: this fact makes these compou…

Quantitative structure–activity relationshipProteasebiologymedicine.medical_treatmentIntegrase inhibitorDrug designGeneral MedicineComputational biologyDe novo design Docking HIV-1 integrase inhibitors Molecular dynamics Molecular modelling Pharmacophore QSARBioinformaticsIntegraseDocking (molecular)Host chromosomeDrug Discoverybiology.proteinmedicineMolecular MedicinePharmacophore
researchProduct

Prospective computational design and in vitro bio-analytical tests of new chemical entities as potential selective CYP17A1 lyase inhibitors

2019

[EN] The development and advancement of prostate cancer (PCa) into stage 4, where it metastasize, is a major problem mostly in elder males. The growth of PCa cells is stirred up by androgens and androgen receptor (AR). Therefore, therapeutic strategies such as blocking androgens synthesis and inhibiting AR binding have been explored in recent years. However, recently approved drugs (or in clinical phase) failed in improving the expected survival rates for this metastatic-castration resistant prostate cancer (mCRPC) patients. The selective CYP17A1 inhibition of 17,20-lyase route has emerged as a novel strategy. Such inhibition blocks the production of androgens everywhere they are found in t…

Quantitative structure–activity relationshipStereochemistry01 natural sciencesBiochemistryStructure-Activity Relationship3D-QSAR pharmacophore modelDrug DiscoveryCytochrome P-450 Enzyme InhibitorsHumansStructure–activity relationshipCYP17A1 InhibitorMolecular BiologyDensity Functional TheoryVirtual screeningDose-Response Relationship DrugMolecular Structure010405 organic chemistryChemistryOrganic ChemistryProspective computational designSteroid 17-alpha-Hydroxylasecomputer.file_format1720-lyase selective inhibitionProtein Data BankLyase0104 chemical sciencesMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)CYP17A1 inhibitorsMetastatic-castration resistant prostate cancerPharmacophorecomputer
researchProduct

Harmonization of QSAR Best Practices and Molecular Docking Provides an Efficient Virtual Screening Tool for Discovering New G-Quadruplex Ligands

2015

Telomeres and telomerase are key players in tumorogenesis. Among the various strategies proposed for telomerase inhibition or telomere uncapping, the stabilization of telomeric G-quadruplex (G4) structures is a very promising one. Additionally, G4 stabilizing ligands also act over tumors mediated by the alternative elongation of telomeres. Accordingly, the discovery of novel compounds able to act on telomeres and/or inhibit the telomerase enzyme by stabilizing DNA telomeric G4 structures as well as the development of approaches efficiently prioritizing such compounds constitute active areas of research in computational medicinal chemistry and anticancer drug discovery. In this direction, we…

Quantitative structure–activity relationshipTelomeraseGeneral Chemical EngineeringDrug Evaluation PreclinicalQuantitative Structure-Activity RelationshipComputational biologyLibrary and Information SciencesBiologyG-quadruplexCrystallography X-RayLigandsMolecular Docking Simulationchemistry.chemical_compoundDrug DiscoveryHumansCell ProliferationGeneticsVirtual screeningMolecular StructureDrug discoveryQSARGeneral ChemistryFibroblastsTelomereComputer Science ApplicationsTelomereG-QuadruplexesMolecular Docking SimulationchemistryAcridinesDNAHeLa Cells
researchProduct

Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes

2015

The adverse effects to humans and environment of only few chemicals are well known. Absorption, distribution, metabolism, and excretion (ADME) are the steps of pharmaco/toxicokinetics that determine the internal dose of chemicals to which the organism is exposed. Of all the xenobiotic-metabolizing enzymes, the cytochrome P450 (CYP) enzymes are the most important due to their abundance and versatility. Reactions catalyzed by CYPs usually turn xenobiotics to harmless and excretable metabolites, but sometimes an innocuous xenobiotic is transformed into a toxic metabolite. Data on ADME and toxicity properties of compounds are increasingly generated using in vitro and modeling (in silico) tools.…

Quantitative structure–activity relationshipcytochrome P450In silicoMetabolitexenobioticReviewBiologyPharmacologyXenobiotics03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCYP P450sToxicokineticsPharmacology (medical)aineenvaihdunta030304 developmental biologyADMEPharmacology0303 health sciencesIn silico modelingQSARlcsh:RM1-950Cytochrome P450docking studiesmodelingLigand (biochemistry)3. Good healthbiotransformationslcsh:Therapeutics. PharmacologychemistryBiochemistryin silico030220 oncology & carcinogenesisbiology.proteinXenobioticmetabolismFrontiers in Pharmacology
researchProduct

Biological activity of organotin(IV) compounds: structural and chemical aspects

2012

Settore CHIM/03 - Chimica Generale E InorganicaAntitumor activity Biomolecules Metabolism Organotin structures QSAR
researchProduct

Fast Training of Self Organizing Maps for the Visual Exploration of Molecular Compounds

2007

Visual exploration of scientific data in life science\ud area is a growing research field due to the large amount of\ud available data. The Kohonen’s Self Organizing Map (SOM) is\ud a widely used tool for visualization of multidimensional data.\ud In this paper we present a fast learning algorithm for SOMs\ud that uses a simulated annealing method to adapt the learning\ud parameters. The algorithm has been adopted in a data analysis\ud framework for the generation of similarity maps. Such maps\ud provide an effective tool for the visual exploration of large and\ud multi-dimensional input spaces. The approach has been applied\ud to data generated during the High Throughput Screening\ud of mo…

Settore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniSelf-organizing mapSimilarity (geometry)Speedupbusiness.industryComputer scienceQSAR ANALYSISProcess (computing)computer.software_genreMachine learningField (computer science)VisualizationData visualizationSimulated annealingNEURAL-NETWORKSALGORITHMArtificial intelligenceData miningbusinesscomputer2007 International Joint Conference on Neural Networks
researchProduct

An approach to identify new antihypertensive agents using Thermolysin as model: In silico study based on QSARINS and docking

2019

Thermolysin is a bacterial proteolytic enzyme, considered by many authors as a pharmacological and biological model of other mammalian enzymes, with similar structural characteristics, such as angiotensin converting enzyme and neutral endopeptidase. Inhibitors of these enzymes are considered therapeutic targets for common diseases, such as hypertension and heart failure. In this report, a mathematical model of Multiple Linear Regression, for ordinary least squares, and genetic algorithm, for selection of variables, are developed and implemented in QSARINS software, with appropriate parameters for its fitting. The model is extensively validated according to OECD standards, so that its robust…

Virtual screeningChemistry(all)StereochemistryGeneral Chemical EngineeringIn silicoThermolysinComputational biology01 natural sciencesDockinglcsh:ChemistryThermolysinLinear regressionVirtual screening010405 organic chemistryChemistryProteolytic enzymesGeneral Chemistry0104 chemical sciences010404 medicinal & biomolecular chemistrylcsh:QD1-999Docking (molecular)Multiple Linear RegressionQSARINSOrdinary least squaresOutlierChemical Engineering(all)AntihypertensiveArabian Journal of Chemistry
researchProduct

Applying pattern recognition methods plus quantum and physico-chemical molecular descriptors to analyze the anabolic activity of structurally diverse…

2008

The great cost associated with the development of new anabolic-androgenic steroid (AASs) makes necessary the development of computational methods that shorten the drug discovery pipeline. Toward this end, quantum, and physicochemical molecular descriptors, plus linear discriminant analysis (LDA) were used to analyze the anabolic/androgenic activity of structurally diverse steroids and to discover novel AASs, as well as also to give a structural interpretation of their anabolic-androgenic ratio (AAR). The obtained models are able to correctly classify 91.67% (86.27%) of the AASs in the training (test) sets, respectively. The results of predictions on the 10% full-out cross-validation test al…

Virtual screeningQuantitative structure–activity relationshipAnabolismChemical PhenomenaQuantitative Structure-Activity RelationshipComputational biologyLDA-assisted QSAR modelLigandsPattern Recognition AutomatedAnabolic AgentsMolecular descriptorCluster AnalysisComputer SimulationVirtual screeningMolecular StructureChemistryChemistry PhysicalDiscriminant AnalysisReproducibility of ResultsGeneral ChemistryLinear discriminant analysisCombinatorial chemistryAnabolic–androgenic ratioComputational MathematicsPattern recognition (psychology)Quantum and physicochemical molecular descriptorQuantum TheorySteroidsAnabolic–androgenic steroidAlgorithmsJournal of computational chemistry
researchProduct